2018
DOI: 10.1111/cmi.12974
|View full text |Cite
|
Sign up to set email alerts
|

Shigellaeffector IpaH4.5 targets 19S regulatory particle subunit RPN13 in the 26S proteasome to dampen cytotoxic T lymphocyte activation

Abstract: Subversion of antigen‐specific immune responses by intracellular pathogens is pivotal for successful colonisation. Bacterial pathogens, including Shigella, deliver effectors into host cells via the type III secretion system (T3SS) in order to manipulate host innate and adaptive immune responses, thereby promoting infection. However, the strategy for subverting antigen‐specific immunity is not well understood. Here, we show that Shigella flexneri invasion plasmid antigen H (IpaH) 4.5, a member of the E3 ubiquit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 33 publications
0
11
0
Order By: Relevance
“…RPN11 inhibitor capzimin [44] and RPT4-binding peptoid RIP-1 were also identified [45] but their activity in vivo is not known. In addition to our molecular series [11,14,15], RPN13 has been targeted with siRNA [12], diphenyldihaloketones CLEFMA and EF24 [46], peptoid approaches [47], thalidomidebased degrader WL40 [48] and, interestingly, Shigella flexneri invasion plasmid antigen H (IpaH) 4.5 is a E3 ubiquitin ligase that induces RPN13 degradation via the proteasome and enhances bacterial pathogenicity [49]. However, identifying 19S RP inhibitors with drug-like properties remains challenging and to date only VLX-1570 has been tested clinically [7].…”
Section: Discussionmentioning
confidence: 99%
“…RPN11 inhibitor capzimin [44] and RPT4-binding peptoid RIP-1 were also identified [45] but their activity in vivo is not known. In addition to our molecular series [11,14,15], RPN13 has been targeted with siRNA [12], diphenyldihaloketones CLEFMA and EF24 [46], peptoid approaches [47], thalidomidebased degrader WL40 [48] and, interestingly, Shigella flexneri invasion plasmid antigen H (IpaH) 4.5 is a E3 ubiquitin ligase that induces RPN13 degradation via the proteasome and enhances bacterial pathogenicity [49]. However, identifying 19S RP inhibitors with drug-like properties remains challenging and to date only VLX-1570 has been tested clinically [7].…”
Section: Discussionmentioning
confidence: 99%
“…Through E3 ubiquitin ligase activities, IpaH4.5 targets and degrades RPN13 results by inhibiting 26S proteasome activities. This outcome leads to the suppression of proteasome-catalyzed peptide and reduction of cross-presentation to CD8+ cell [ 165 ].…”
Section: Introductionmentioning
confidence: 99%
“…Inhibition of antigen presentation . Pertussis toxin from Bordetella ( 80 ), EsxG, EsxH ( 244 ), Vpu from HIV-1 ( 245 ), ORF66 from HHV-3 ( 246 ), BILF1 ( 247 , 248 ), BNLF2a ( 249 251 ), and BZLF1 from HHV-4 ( 252 ), E1A and E3 from human adenovirus ( 253 , 254 ), LpqH ( 255 , 256 ), LprA ( 257 ), LprG ( 258 ), and PPE38 ( 259 ) from M. tuberculosis , SteD from Salmonella ( 260 ), and IpaH4.5 from Shigella ( 261 ) inhibit host antigen presentation by various mechanisms.…”
Section: Identifying and Assessing Sequences Of Concernmentioning
confidence: 99%